Fentanyl: Are we paying too high price?

Journal of Opioid Management

Volumn 3, Issue 3, 2007, Pages 123-126

  Fodale, Vincenzo ^a   Romeo, Manuela ^a   Mafrica, Federica ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; DIAMORPHINE; FENTANYL; METHADONE; MIDAZOLAM; MORPHINE; NARCOTIC ANALGESIC AGENT; NITROUS OXIDE; OXYCODONE; THIOPENTAL;

ANESTHESIA; COMA; DEATH; DRUG ABUSE; DRUG METABOLISM; DRUG OVERDOSE; EDITORIAL; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MUSCLE RIGIDITY; NAUSEA AND VOMITING; OPIATE ADDICTION; PAIN; PHARMACOGENOMICS; PREVALENCE; PUBLIC HEALTH; RESPIRATION DEPRESSION; RISK ASSESSMENT; SEDATION; WITHDRAWAL SYNDROME;

EID: 34547828015     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2007.0049     Document Type: Editorial

References (43)

1. Boddiger D: Fentanyl-laced street drugs "kill hundreds." Lancet. 2006; 368(9535): 569-570.
2. Fodale V, Mafrica F, Santamaria LB: Killer fentanyl: A lesson from anaesthesiology. Lancet. 2006; 368(9543): 1237-1238.
3. Drummer OH: Recent trends in narcotic deaths. Ther Drug Monit. 2005; 27(6): 738-740.
4. Henderson GL: Designer drugs: Past history and future prospects. J Forensic Sci. 1988; 33(2): 569-575.
5. Henderson GL: Fentanyl-related deaths: Demographics, circumstances, and toxicology of 112 cases. J Forensic Sci. 1991; 36(2): 422-433.
6. Siegel RK: New trends in drug use among youth in California. Bull Narc. 1985; 37(2-3): 7-17.
7. Smialek JE, Levine B, Chin L, et al.: A fentanyl epidemic in Maryland 1992. J Forensic Sci. 1994; 39(1): 159-164.
8. Bicudo JN, de Souza N, Mangia CM, et al.: Withdrawal syndrome associated with cessation of fentanyl and midazolam in pediatrics. Rev Assoc Med Bras. 1999; 45(1): 15-18.
9. Takara I, Tomiyama H, Tokumine J, et al.: [Withdrawal syndrome in a critically ill child after sedation with midazolam and fentanyl]. Masui. 2004; 53(7): 791-794.
10. Cammarano WB, Pittet JF, Weitz S, et al.: Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med. 1998; 26(4): 676-684.
11. Anderson DT, Muto JJ: Duragesic transdermal patch: Postmortem tissue distribution of fentanyl in 25 cases. J Anal Toxicol. 2000; 24(7): 627-634.
12. Kuhlman JJ Jr, McCaulley R, Valouch TJ, et al.: Fentanyl use, misuse, and abuse: A summary of 23 postmortem cases. J Anal Toxicol. 2003; 27(7): 499-504.
13. Jin M, Gock SB, Jannetto PJ, et al.: Pharmacogenomics as molecular autopsy for forensic toxicology: Genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases. J Anal Toxicol. 2005; 29(7): 590-598.
14. Shavit Y, Ben-Eliyahu S, Zeidel A, et al.: Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation. 2004; 11(4): 255-260.
15. Franck LS, Naughton I, Winter I: Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients. Intensive Crit Care Nurs. 2004; 20(6): 344-351.
16. Taha J, Favre J, Janszen M, et al.: Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable Synchro Med pumps. Neurosurgery. 2004; 55: 390-393.
17. Jackson FW: Fentanyl and the wooden chest. Gastroenterology. 1994; 106(3): 820-821.
18. Viscomi CM, Bailey PL: Opioid-induced rigidity after intravenous fentanyl. Obstet Gynecol. 1997; 89(5 Pt 2): 822-824.
19. Bouillon T, Bruhn J, Roepcke H, et al.: Opioid-induced respiratory depression is associated with increased tidal volume variability. Eur J Anaesthesiol. 2003; 20(2): 127-133.
20. Clark JD, Edwards T: Severe respiratory depression in a patient with gastroparesis while receiving opioids for pain. Clin J Pain. 1999; 15(4): 321-323.
21. McLoughlin R, McQuillan R: Transdermal fentanyl and respiratory depression. Palliat Med. 1997; 11(5): 419.
22. Tsou CH, Luk HN: Fentanyl-induced coughing and airway hyperresponsiveness. Acta Anaesthesiol Sin. 2002; 40(4): 165-172.
23. Ananthanarayan C: Tussive effect of fentanyl. Anaesthesia. 1990; 45(7): 595.
24. Arandia HY, Patil VU: Glottic closure following large doses of fentanyl. Anaesthesiology. 1987; 66(4): 574-575.
25. Gin T, Chui PT: Coughing after fentanyl. Can J Anaesth. 1992; 39(4): 406.
26. Yu SY, Sun Y, Wu YL, et al.: [Transdermal fentanyl for the management of cancer pain: A survey of 4492 patients]. Zhonghua Zhong Liu Za Zhi. 2005; 27(6): 369-372.
27. Okamura K, Sanuki M, Kinoshita H, et al.: [Study of nausea and vomiting accompanying intravenous patient-controlled analgesia with fentanyl after cervical spine surgery]. Masui. 2003; 52(11): 1181-1185.
28. Hansen-Flaschen J, Adler BS: Allegations of sexual abuse in an intensive care unit. Crit Care Med. 1999; 27(2): 437-440.
29. Nevin J: Drug update: Fentanyl patch abuse. Emerg Med Serv. 2004; 33(7): 24-25.
30. Compton WM, Volkow ND: Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006; 83 Suppl 1: S4-S7.
31. Lilleng PK, Mehlum LI, Bachs L, et al.: Deaths after intravenous misuse of transdermal fentanyl. J Forensic Sci. 2004 49(6): 1364-1366.
32. Jost U, Wolter E, Bohrer H: [Repeated improper intravenous injection of fentanyl from a transdermal system]. Dtsch Med Wochenschr. 2004; 129(7): 313-314.
33. Holth LS, Friesen R, Green C, et al.: A simple method for quantifying fentanyl, sufentanil, or morphine in discard syringes from anesthesia procedures. Ther Drug Monit. 2002; 24(5): 665-669.
34. Moore NN, Bostwick JM: Ketamine dependence in anaesthesia providers. Psychosomatics. 1999; 40(4): 356-359.
35. Kintz P, Villain M, Dumestre V, et al.: Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic Sci Int. 2005; 153(1): 81-84.
36. Schwartz JG, Garriott JC, Somerset JS, et al.: Measurements of fentanyl and sufentanil in blood and urine after surgical application. Implication in detection of abuse. Am J Forensic Med Pathol. 1994; 15(3): 236-241.
37. Gold MS, Byars JA, Frost-Pineda K: Occupational exposure and addictions for physicians: Case studies and theoretical implications. Psychiatr Clin North Am. 2004; 27(4): 745-753.
38. McAuliffe PF, Gold MS, Bajpai L, et al.: Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses. 2006; 66(5): 874-882.
39. Gold MS, Melker RJ, Dennis DM, et al.: Fentanyl abuse and dependence: Further evidence for second hand exposure hypothesis. J Addict Dis. 2006; 25(1): 15-21.
40. Domino KB, Hornbein TF, Polissar NL, et al.: Risk factors for relapse in health care professionals with substance use disorders. JAMA. 2005; 293(12): 1513-1515.
41. Ward CF, Ward GC, Saidman LJ: Drug abuse in anesthesia training programs. A survey: 1970 through 1980. JAMA. 1983; 250(7): 922-925.
42. Thompson ES: Where is the fentanyl? Anesthesiology. 2004; 101(1): 265.
43. Skulska A, Kala M, Parczewski A: Fentanyl and its analogues in clinical and forensic toxicology. Prz Lek. 2005; 62(6): 581-584.